BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22879062)

  • 21. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
    Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
    J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival.
    Yoshida Y; Nakada M; Sugimoto N; Harada T; Hayashi Y; Kita D; Uchiyama N; Hayashi Y; Yachie A; Takuwa Y; Hamada J
    Int J Cancer; 2010 May; 126(10):2341-52. PubMed ID: 19810093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
    Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
    J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
    Miletic H; Fischer YH; Neumann H; Hans V; Stenzel W; Giroglou T; Hermann M; Deckert M; Von Laer D
    Hum Gene Ther; 2004 Nov; 15(11):1091-100. PubMed ID: 15610609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT signaling in glioma cells.
    Swiatek-Machado K; Kaminska B
    Adv Exp Med Biol; 2013; 986():189-208. PubMed ID: 22879070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
    Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
    Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium dependence of purinergic subtype P2Y₁ receptor modulation of C6 glioma cell migration.
    Jantaratnotai N; McLarnon JG
    Neurosci Lett; 2011 Jun; 497(2):80-4. PubMed ID: 21540076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathogenesis of malignant glial tumors.
    Jones TS; Holland EC
    Toxicol Pathol; 2011 Jan; 39(1):158-66. PubMed ID: 21078918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Communication between malignant glioma cells and vascular endothelial cells through gap junctions.
    Zhang W; DeMattia JA; Song H; Couldwell WT
    J Neurosurg; 2003 Apr; 98(4):846-53. PubMed ID: 12691411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
    Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
    Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.
    Goidts V; Bageritz J; Puccio L; Nakata S; Zapatka M; Barbus S; Toedt G; Campos B; Korshunov A; Momma S; Van Schaftingen E; Reifenberger G; Herold-Mende C; Lichter P; Radlwimmer B
    Oncogene; 2012 Jul; 31(27):3235-43. PubMed ID: 22056879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
    Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
    Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.